1
|
Iqbal U, Hsu YHE, Celi LA, Li YCJ. Artificial intelligence in healthcare: Opportunities come with landmines. BMJ Health Care Inform 2024; 31:e101086. [PMID: 38839426 PMCID: PMC11163668 DOI: 10.1136/bmjhci-2024-101086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Accepted: 05/02/2024] [Indexed: 06/07/2024] Open
Affiliation(s)
- Usman Iqbal
- School of Population Health, Faculty of Medicine and Health, University of New South Wales (UNSW), Sydney, NSW, Australia
- Global Health and Health Security Department, College of Public Health, Taipei Medical University, Taipei, Taiwan
- International Center for Health Information and Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Yi-Hsin Elsa Hsu
- Biotechnology Executive Master's Degree in Business Administration (BioTech EMBA), Taipei Medical University, Taipei, Taiwan
- School of Healthcare Administration, College of Management, Taipei Medical University, Taipei, Taiwan
- International Ph.D. Program in BioTech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan
- Department of Humanities in Medicine, College of Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Leo Anthony Celi
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
- Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
| | - Yu-Chuan Jack Li
- International Center for Health Information and Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
- Graduate Institute of Biomedical Informatics, College of Medical Science & Technology, Taipei Medical University, Taipei, Taiwan
- Department of Dermatology, Taipei Municipal Wanfang Hospital, Taipei, Taiwan
- The International Medical Informatics Association (IMIA), Zürich, Switzerland
| |
Collapse
|
2
|
Lo Gullo R, Brunekreef J, Marcus E, Han LK, Eskreis-Winkler S, Thakur SB, Mann R, Groot Lipman K, Teuwen J, Pinker K. AI Applications to Breast MRI: Today and Tomorrow. J Magn Reson Imaging 2024. [PMID: 38581127 DOI: 10.1002/jmri.29358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 03/07/2024] [Accepted: 03/09/2024] [Indexed: 04/08/2024] Open
Abstract
In breast imaging, there is an unrelenting increase in the demand for breast imaging services, partly explained by continuous expanding imaging indications in breast diagnosis and treatment. As the human workforce providing these services is not growing at the same rate, the implementation of artificial intelligence (AI) in breast imaging has gained significant momentum to maximize workflow efficiency and increase productivity while concurrently improving diagnostic accuracy and patient outcomes. Thus far, the implementation of AI in breast imaging is at the most advanced stage with mammography and digital breast tomosynthesis techniques, followed by ultrasound, whereas the implementation of AI in breast magnetic resonance imaging (MRI) is not moving along as rapidly due to the complexity of MRI examinations and fewer available dataset. Nevertheless, there is persisting interest in AI-enhanced breast MRI applications, even as the use of and indications of breast MRI continue to expand. This review presents an overview of the basic concepts of AI imaging analysis and subsequently reviews the use cases for AI-enhanced MRI interpretation, that is, breast MRI triaging and lesion detection, lesion classification, prediction of treatment response, risk assessment, and image quality. Finally, it provides an outlook on the barriers and facilitators for the adoption of AI in breast MRI. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 6.
Collapse
Affiliation(s)
- Roberto Lo Gullo
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
| | - Joren Brunekreef
- AI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - Eric Marcus
- AI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - Lynn K Han
- Weill Cornell Medical College, New York-Presbyterian Hospital, New York City, New York, USA
| | - Sarah Eskreis-Winkler
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
| | - Sunitha B Thakur
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
| | - Ritse Mann
- AI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Kevin Groot Lipman
- AI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Jonas Teuwen
- AI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Katja Pinker
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
| |
Collapse
|
3
|
Marcus E, Teuwen J. Artificial intelligence and explanation: How, why, and when to explain black boxes. Eur J Radiol 2024; 173:111393. [PMID: 38417186 DOI: 10.1016/j.ejrad.2024.111393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2024] [Accepted: 02/22/2024] [Indexed: 03/01/2024]
Abstract
Artificial intelligence (AI) is infiltrating nearly all fields of science by storm. One notorious property that AI algorithms bring is their so-called black box character. In particular, they are said to be inherently unexplainable algorithms. Of course, such characteristics would pose a problem for the medical world, including radiology. The patient journey is filled with explanations along the way, from diagnoses to treatment, follow-up, and more. If we were to replace part of these steps with non-explanatory algorithms, we could lose grip on vital aspects such as finding mistakes, patient trust, and even the creation of new knowledge. In this article, we argue that, even for the darkest of black boxes, there is hope of understanding them. In particular, we compare the situation of understanding black box models to that of understanding the laws of nature in physics. In the case of physics, we are given a 'black box' law of nature, about which there is no upfront explanation. However, as current physical theories show, we can learn plenty about them. During this discussion, we present the process by which we make such explanations and the human role therein, keeping a solid focus on radiological AI situations. We will outline the AI developers' roles in this process, but also the critical role fulfilled by the practitioners, the radiologists, in providing a healthy system of continuous improvement of AI models. Furthermore, we explore the role of the explainable AI (XAI) research program in the broader context we describe.
Collapse
Affiliation(s)
- Eric Marcus
- AI for Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
| | - Jonas Teuwen
- AI for Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands
| |
Collapse
|
4
|
Pinker K. Implementing AI in breast imaging: challenges to turn the gadget into gain. Eur Radiol 2024; 34:2093-2095. [PMID: 37667145 DOI: 10.1007/s00330-023-10205-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 08/07/2023] [Accepted: 08/17/2023] [Indexed: 09/06/2023]
Affiliation(s)
- Katja Pinker
- Department of Radiology - Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66Th Street, Room 707, New York, NY, 10065, USA.
| |
Collapse
|
5
|
Alanzi T, Alotaibi R, Alajmi R, Bukhamsin Z, Fadaq K, AlGhamdi N, Bu Khamsin N, Alzahrani L, Abdullah R, Alsayer R, Al Muarfaj AM, Alanzi N. Barriers and Facilitators of Artificial Intelligence in Family Medicine: An Empirical Study With Physicians in Saudi Arabia. Cureus 2023; 15:e49419. [PMID: 38149160 PMCID: PMC10750222 DOI: 10.7759/cureus.49419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/23/2023] [Indexed: 12/28/2023] Open
Abstract
BACKGROUND Artificial intelligence (AI) is a novel technology that has been widely acknowledged for its potential to improve the processes' efficiency across industries. However, its barriers and facilitators in healthcare are not completely understood due to its novel nature. STUDY PURPOSE The purpose of this study is to explore the intricate landscape of AI use in family medicine, aiming to uncover the factors that either hinder or enable its successful adoption. METHODS A cross-sectional survey design is adopted in this study. The questionnaire included 10 factors (performance expectancy, effort expectancy, social influence, facilitating conditions, behavioral intention, trust, perceived privacy risk, personal innovativeness, ethical concerns, and facilitators) affecting the acceptance of AI. A total of 157 family physicians participated in the online survey. RESULTS Effort expectancy (μ = 3.85) and facilitating conditions (μ = 3.77) were identified to be strong influence factors. Access to data (μ = 4.33), increased computing power (μ = 3.92), and telemedicine (μ = 3.78) were identified as major facilitators; regulatory support (μ = 2.29) and interoperability standards (μ = 2.71) were identified as barriers along with privacy and ethical concerns. Younger individuals tend to have more positive attitudes and expectations toward AI-enabled assistants compared to older participants (p < .05). Perceived privacy risk is negatively correlated with all factors. CONCLUSION Although there are various barriers and concerns regarding the use of AI in healthcare, the preference for AI use in healthcare, especially family medicine, is increasing.
Collapse
Affiliation(s)
- Turki Alanzi
- Department of Health Information Management and Technology, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam, SAU
| | - Raghad Alotaibi
- Department of Family Medicine, King Fahad Medical City, Riyadh, SAU
| | - Rahaf Alajmi
- College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU
| | - Zainab Bukhamsin
- College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, SAU
| | - Khadija Fadaq
- College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU
| | - Nouf AlGhamdi
- College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU
| | | | | | - Ruya Abdullah
- Faculty of Medicine, Ibn Sina National College, Jeddah, SAU
| | - Razan Alsayer
- College of Medicine, Northern Border University, Arar, SAU
| | - Afrah M Al Muarfaj
- Department of Health Affairs, General Directorate of Health Affairs in Assir Region, Ministry of Health, Abha, SAU
| | - Nouf Alanzi
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah, SAU
| |
Collapse
|